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Abstract
Background: Candidate gene case-control studies have identified several single nucleotide polymorphisms (SNPs) that are
associated with asthma susceptibility. Most of these studies have been restricted to evaluations of specific SNPs within a
single gene and within populations from European ancestry. Recently, there is increasing interest in understanding racial
differences in genetic risk associated with childhood asthma. Our aim was to compare association patterns of asthma
candidate genes between children of European and African ancestry.
Methodology/Principal Findings: Using a custom-designed Illumina SNP array, we genotyped 1,485 children within the
Greater Cincinnati Pediatric Clinic Repository and Cincinnati Genomic Control Cohort for 259 SNPs in 28 genes and
evaluated their associations with asthma. We identified 14 SNPs located in 6 genes that were significantly associated (p-
values ,0.05) with childhood asthma in African Americans. Among Caucasians, 13 SNPs in 5 genes were associated with
childhood asthma. Two SNPs in IL4 were associated with asthma in both races (p-values ,0.05). Gene-gene interaction
studies identified race specific sets of genes that best discriminate between asthmatic children and non-allergic controls.
Conclusions/Significance: We identified IL4 as having a role in asthma susceptibility in both African American and
Caucasian children. However, while IL4 SNPs were associated with asthma in asthmatic children with European and African
ancestry, the relative contributions of the most replicated asthma-associated SNPs varied by ancestry. These data provides
valuable insights into the pathways that may predispose to asthma in individuals with European vs. African ancestry.
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Introduction
Asthma (MIM 600807) is a disease of chronic airway
inflammation characterized by recurrent episodes of wheezing,
dyspnea, chest tightness, and cough. It affects nearly 300 million
individuals worldwide including 20 million adults and children in
the United States [1,2]. Approximately 5,000 asthma deaths occur
in the US every year [3]. Previous studies have revealed strong
familial aggregation with heritability estimates between 36 and
79%, supporting the existence of asthma susceptibility genes.
Indeed, more than 120 genes have been found to be associated
with asthma- or atopy-related phenotypes as reported in greater
than 600 studies [4].
While many studies have evaluated the importance of genetics
on asthma susceptibility, most studies employ samples from
populations of European descent. Few have focused on asthma
risk in African Americans, despite the fact that asthma morbidity
and mortality are more prevalent in this subgroup. In the PubMed
database, European populations are mentioned 5 times more often
in various asthma related literature than African Americans
(http://www.ncbi.nlm.nih.gov). Studies in other ethnicities, par-
ticularly African-derived populations, are valuable, because they
may help localize the signals of association and because additional
variants present at high frequency in African-derived populations
may be absent or rare in Caucasian samples [5]. Furthermore, it is
not clear whether associations with asthma found in the Caucasian
samples can be consistently replicated in samples from predom-
inantly recent African ancestry. Genetic, environmental or
phenotypic heterogeneity, gene-gene and gene by environment
interactions or different recombination histories between popula-
tions could all contribute to a lack of replication in African-derived
populations. Genetic variants may also have different effects in
different populations because of unmeasured (and perhaps
unknown) environmental risk factors. Hence, the prognostic utility
value of specific variants for asthma risk assessment differs across
populations [6]. Given the greater genetic diversity and different
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ancestry populations, understanding genetic variation in asthma
related genes in African American population could provide novel
insights into the etiology of asthma.
Therefore, the objective of this study was to identify the
similarities and differences in association patterns of asthma and
known candidate genes between European ancestry and African
American children. To accomplish this objective, we used a
carefully collected cohort of children from the greater Cincinnati
area as the discovery cohort and an independent replication
cohort of Caucasians and publicly available dataset of African
Americans.
Materials and Methods
Study population
The analysis included Caucasian and African American
asthmatic, allergic and non-allergic children enrolled in the
Greater Cincinnati Pediatric Clinic Repository (GCPCR) and
Cincinnati Genomic Control Cohort (GCC) and who met the case
and control definitions (outlined below). Recruitment for GCPCR
began in November, 2003 and is ongoing. Children with asthma
and other allergic conditions visiting the allergy/immunology,
pulmonary, and dermatology outpatient specialty clinics and from
the Emergency Department at CCHMC were invited to
participate in the GCPCR. Non-allergic control children were
recruited into GCPCR from headache, dental and orthopedic
clinics as well as from the community at large using paper and
online advertising media. Following written informed consent,
participants were asked to provide a buccal (using a cytobrush) or
saliva sample (Oragene DNA Self-Collection Kit, DNA Genotek
Inc., Ottawa, ON Canada) for DNA isolation and to complete
repository specific questionnaires. The GCC is an ongoing
community-based cohort of over 1,020 healthy children ages 3–
18 years old. In terms of race, ethnicity, gender, and socioeco-
nomic status, participants are representative of the 7 counties that
cover the Greater Cincinnati region. Participating GCC children
provided a blood sample for DNA isolation at their baseline visit.
For these genetic association studies, GCPCR participants aged 4
to 17 years with physician diagnosed asthma based on the ATS
criteria [7] (with or without allergic rhinitis and/or atopic
dermatitis), and available pulmonary function test results and/or
respiratory symptom scores were included as asthmatic cases.
Similar aged non-asthmatic GCPCR children with allergic rhinitis
and/or atopic dermatitis or non-asthmatic GCC children who
reported ever having hay fever or eczema were included as allergic
children. Children from either GCPCR or the GCC were
included as non-allergic controls if they reported not having any
personal or family history of asthma, and not having a personal
history of any allergic disorder. Written informed consent was
obtained from all interested patients and their parents/guardians.
The study was approved by the Cincinnati Children’s Hospital
Medical Center Institutional Review Board.
Replication cohorts
The Caucasian replication population includes asthmatic
children from the GCC compared to non-asthmatic adults with
no family history of asthma from the Cincinnati Control Cohort
(CCC). Like the GCC, the CCC is a population-based sample of
298 Caucasians (age 24–90 years) from the Greater Cincinnati/
Northern Kentucky area. The African American replication
populations were 42 African American trios (126 individual
samples) from the Childhood Asthma Management Program
(CAMP) data available from the NIH-based database of
Genotypes and Phenotypes (dbGaP) (http://www.ncbi.nlm.nih.
gov/gap) Formal permission for use of the dbGaP data was
obtained prior to analysis. Both the Caucasian and African
American replication cohorts were genotyped using Affymetrix 6.0
SNP chip.
Candidate gene and SNP selection, and genotyping
We conducted a large-scale evaluation of candidate genes to
identify common variants that influence asthma risk. A total of 28
candidate genes were selected for inclusion in a custom Illumina
GoldenGate
TM assay. To investigate asthma liability genes
systematically, we selected 28 candidate genes. These candidates
were chosen based on a high number of replications in the
literature (.10) [8] and biologic relevance in the pathogenesis of
asthma or allergy. The description of candidate genes including
function and process terms deposited in the Gene Ontology (GO)
databases (http://www.geneontology.org; [^] accessed on June 20,
2010) are shown in Table 1.
SNPs for this chip were selected in one of two ways. First, non-
synonymous SNPs or SNPs in regulatory or coding regions were
selected. Second, tagging SNPs that efficiently capture all the
common genetic variation in a gene were selected using Haplo-
view and Tagger (http://www.broad.mit.edu/mpg/haploview).
The rationale for tagging SNPs is that genetic variants that are
near each other and in linkage disequilibrium (LD) tend to be
inherited together as a result of shared ancestry. The strong
correlations between markers within haplotype blocks help to
enable accurate representation of a gene region by a small number
of tagging SNPs. The SNPs were retrieved from Caucasians in the
United States with northern and western European ancestry
[CEU] and Yorubans in Ibadan, Nigeria [YRI] population
samples of the public HapMap database (http://hapmap.ncbi.
nlm.nih.gov). Genotyping using the Illumina GoldenGate Assay
(http://www.illumina.com) system was performed at the CCHMC
Genetic Variation and Gene Discovery Core. Genotypes were
assigned using Illumina’s BeadStudio v3.2 Software (San Diego,
CA).
Statistical analysis
All analyses were performed separately in Caucasian and
African American datasets. Prior to analysis, SNPs which failed
Hardy Weinberg Equilibrium (HWE) in the control dataset
(p,0.0001) or had poor genotype calling (missing rate greater
than 10%) or minor allele frequencies below 10% were excluded
from the analysis. In addition, individuals with more than 20% of
their total SNPs missing were also removed from the analysis. To
account for potential population stratification/confounding or
admixture in these samples, principal component analyses (PCA)
was performed using 30 unlinked Ancestry Informative Markers
(AIMs) and the EIGENSTRAT software [9]. The principal
component score for each individual was included as a covariate in
all models along with age and gender in logistic regression models.
Statistical comparisons in both Caucasians and African
Americans were made between asthmatic children and non-
allergic controls and also between the allergic children and the
non-allergic controls. As a general association screen, we tested for
the additive models of single SNP analysis, which assume that each
copy of the risk allele will increase disease prevalence. Uncondi-
tional logistic regression was used to calculate p-values and odds
ratios for each SNP using the software PLINK (V1.05) and
Bonferroni adjustment that scales the original threshold by the
number of tests performed was used to correct for multiple testing
and determine the statistical significance of each SNP [10]. To
investigate the relationship between IL4 and IL13 genes, linkage
Racial Differences in Childhood Asthma
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Gene symbol Gene name Chr location
SNPs
genotyped* Gene Ontology Terms (www.geneontology.org)
Process Function
ATPAF1 Apoptotic protease
activating factor 1
1p33 3 (1) protein complex assembly
CHI3L2 chitinase3like 2 1p13 13 (9) carbohydrate metabolic process, chitin
catabolic process
cation binding, hydrolase
activity
CHIA chitinase 1p13.2 31(23) cell wall chitin metabolic process, immune
response, polysaccharide catabolic process,
response to fungus, response to acid
cation binding, chitin binding,
lysozyme activity, sugar
binding
CLCA1 chloride channel accessory 1 1p22.3 29 (24)
FLG filaggrin 1q21.3 12 (6) keratinocyte differentiation, multicellular
development
calcium ion binding, structural
molecule activity
IL10 interleukin 10 1q32.1 10 (9) B cell differentiation, T-helper 2 type immune
response, defense response to bacterium,
immune response, inflammatory response,
receptor biosynthetic process, negative
regulation of interleukin12
cytokine activity, interleukin10
receptor binding, protein
binding
INSIG2 insulin induced gene 2 2q14.1 9 (9) cholesterol metabolic process, lipid metabolic
process, response to sterol depletion, steroid
metabolic process
protein binding
NFE2L2 nuclear factor
erythroidderived 2like 2
2q31.2 8 (5) regulation of transcription, DNA dependent
transcription from RNA polymerase II promoter
sequencespecific DNA binding,
transcription factor activity
ADIPOQ adiponectin, C1Q and
collagen domain
containing
3q27.3 13 (10) fatty acid betaoxidation, generation of precursor
metabolites and energy, protein/glucose
homeostasis, lowdensity lipoprotein particle
clearance, negative regulation of inflammatory
response
cytokine activity, eukaryotic
cell surface binding, protein
homodimerization activity
ADRB2 adrenergic, beta2,
receptor, surface
5q33.1 9 (6) Gprotein coupled receptor protein signaling
pathway, receptormediated endocytosis,
negative regulation of inflammatory response
beta2adrenergic receptor
activity, potassium channel
regulator activity, receptor
activity
IL13 interleukin 13 5q31.1 7 (6) cell motion, cellcell signaling, immune response,
inflammatory response, signal transduction
cytokine activity, interleukin13
receptor binding,
IL4 interleukin 4 5q3135 10 (7) B cell differentiation, Thelper 2 type immune
response, cellular defense response, cholesterol
metabolic process, regulation of immune
response, positive regulation of isotype
switching to IgE isotypes
cytokine activity interleukin4
receptor, binding
IL9 interleukin 9 5q31.1 5 (5) immune response, inflammatory response
positive regulation of cell proliferation positive
regulation of interleukin5 biosynthetic process
cytokine activity growth
factor activity cytokine
receptor binding
SPINK5 serine protease inhibitor
Kazal type 5
5q33.1 19 (13) negative regulation of immune response,
regulation of T cell differentiation,
epithelial cell differentiation
serinetype endopeptidase
inhibitor activity
TSLP thymic stromal
lymphopoietin
5q22.1 9 (9) cytokine activity
CCL26 eotaxin3 7q11.23 10 (5) Chemotaxis, immune response inflammatory
response, signal transduction
chemokine activity
SERPINE1 serpin peptidase inhibitor,
clade E, member 1
7q22.1 20 (9) chronological cell aging fibrinolysis, regulation of
angiogenesis
protease binding, protein
binding, serinetype
endopeptidase activity
ALOX5 arachidonate 5lipoxy
genase
10q11.21 14 (13) inflammatory response, leukotriene biosynthetic
process, oxidation reduction
arachidonate 5lipoxygenase
activity, calcium ion binding
SPI1 spleen focus forming virus
proviral integration spi1
11p11.2 8 (7) negative regulation of transcription from RNA
polymerase II promoter, positive regulation of
genespecific, transcription
protein binding,
sequencespecific DNA binding
SERPINA1 serpin peptidase inhibitor,
clade A (alpha1
antiproteinase, antitrypsin),
member 1
14q32.1 15 (15) acutephase response, blood coagulation peptidase activity, peptidase
inhibitor activity, protease
binding, protein binding,
serinetype endopeptidase
inhibitor activity
CIITA class II, major
histocompatibility complex
16p13.13 13 (8) immune response, regulation of transcription,
DNAdependent, response to antibiotic
protein binding, transcription
coactivator activity
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Caucasians and African Americans using Haploview version 4.1
[11]. Results were evaluated after correcting for multiple testing
using a Bonferroni adjustment taking into account LD correlation
between SNPs.
To compare the allele frequencies between Caucasian and
African Americans asthmatic and non-allergic controls, we used
the absolute allele frequency difference also called delta (d). It is
defined as the absolute value of the difference of the frequency of a
particular allele observed between the two populations. If we let
P11 represent the frequency of allele in the first population and P21
the frequency of the same allele in the second population, then
d=|P 112P21|. A marker with d=1 provides perfect information
regarding ancestry whereas a marker with d=0 carries no
information [12].
Recursive partitioning (RP) was used to evaluate gene-gene
interactions using the R package PARTY (v0.9-995; www.r-
project.org). The purpose of RP is to identify the optimum
combination of SNPs that best discriminate between asthmatic
and control subjects. RP uses a series of regressions to identify
covariates (in this case SNPs) which best splits the data into distinct
homogeneous strata (e.g. those at high risk of asthma versus those
at low risk of asthma). A conditional inference tree was built by
first identifying the SNP (in this case, rs2243250 in IL4) which best
discriminates asthma cases and non-allergic controls and imple-
menting a binary split. Then the groups of children along each
subsequent branch are treated as individual datasets and the
regression analysis was repeated to identify the SNP that next best
discriminates between asthma cases and controls. This process is
repeated over and over for each of the resulting subsets until the
stopping rules are met. We used the significance level of the
conditional independence tests as a=0.05 for our stopping
criterion and the minimum number of children in a node
considered for splitting was 200 for Caucasian and 80 for African
American. The variable selection procedure and the stopping rules
allow the application of statistical test procedures to minimize
over-fitting issues [13]. Using the predict function, we then classed
individuals as affected or unaffected based on the final tree, and
used the predicted and actual disease status to calculate
classification accuracy. In contrast to traditional diagnostic tests,
such as cluster analysis [14], that typically classify patients into one
of two groups, RP results identify several genetically characterized
groups with associated asthma risk ranging from very low to very
high.
We used Ingenuity Pathways Analysis (IPA) 8.6 (Ingenuity
Systems, Mountain View, CA, USA), to demonstrate whether the
RP interacting genes are part of an integrated and interconnected
biological networks that involved in genes that have functional
commonalities in both races. A data set containing RP gene
identifiers was uploaded into IPA to map and generate putative
networks based on the manually curated knowledge database of
pathway interactions extracted from the literature. The gene
network was generated using both direct and indirect relation-
ships/connectivity. These networks were ranked by scores that
measured the probability that the genes were included in the
network by chance alone.
SNP Imputation
For the replication Caucasian (GCC cases and CCC controls)
and African American dbGaP (CAMP trio dataset) populations,
we utilized the available genotyping data from the Affymetrix 6.0
SNP chip (http://www.ncbi.nlm.nih.gov/gap). However, none of
the five IL4 SNPs evaluated in our Caucasian population and only
two SNPs in African American populations were present on the
AffymetrixH 6.0 SNP chip. Imputation was performed to infer
genotypes at untyped markers using MACH 1.0.16 (http://www.
sph.umich.edu/csg/MaCH), which uses a hidden Markov model
to estimate an underlying set of unphased genotypes for each
individual in a cohort. We used information on patterns of
haplotype variation in the HapMap CEU and YRI samples
(release 22) as our reference haplotype. We only considered SNPs
that were either genotyped or could be imputed with relatively
high quality (RSQ .0.4). The estimated mismatch rate in Markov
model is about 0.001 for both populations.
For the Caucasian population, both imputed and genotyped
SNPs were tested for association with asthma status using additive
logistic regression models in PLINK. For the dbGaP CAMP
dataset, association analysis was performed using the transmission
Gene symbol Gene name Chr location
SNPs
genotyped* Gene Ontology Terms (www.geneontology.org)
Process Function
IL4Ra interleukin 4Ra 16p11 31 (16) immune response, signal transduction interleukin4 receptor activity
protein binding, receptor
activity
STUB1 STIP1 homology and
Ubox protein 1
16p13.3 4 (1) protein polyubiquitination, regulation of
glucocorticoid metabolic process,
ubiquitindependent SMAD protein catabolic
process
Hsp70 protein binding,
HRH4 histamine receptor H4 18q11.2 14 (11) Gprotein coupled receptor protein signaling
pathway, signal transduction
histamine receptor activity,
TGFB1 transforming growth
factor, beta 1
19q13.2 5 (4) positive regulation of interleukin17 production,
induction of apoptosis, inflammatory response,
lymph node development
protein Nterminus binding type
II transforming growth factor
CDH26 cadherinlike 26 20q13.33 12 (8) integral to membrane, plasma membrane homophilic cell adhesion
IL13RA1 interleukin 13R1 Xq24 17 (14) receptor activity
IL13RA2 interleukin 13R2 Xq13 5 (4) extracellular space, integral to membrane cytokine receptor activity
*numbers in parentheses indicates number of SNPs that passed quality control and enter to statistical analysis.
doi:10.1371/journal.pone.0016522.t001
Table 1. Cont.
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The TDT test evaluates the observed number of parent-offspring
transmissions of alleles, compared with the number of transmis-
sions expected by chance. Only parents heterozygous for the
polymorphism tested are informative for the test. Association was
tested using chi-square statistics. We applied imputation methods
to validate our initial association and expands the test to untyped
variants.
Results
Demographics of cases and controls
Basic descriptive statistics of the study populations by race is
provided in Table 2. The mean age of Caucasian children was
significantly less for asthmatic and allergic children compared to
the non-allergic controls (p,0.0001). For African American
children, there were significantly more males than females in the
asthma group compared to both the allergic control group
(p=0.004) and non-allergic control group (p=0.02). Therefore,
associations between asthmatics and non-allergic children and
between allergic children and non-allergic children were adjusted
for age and gender in addition to population stratification.
Allele frequencies vary by race
A comparison of allele frequency differences for 111 out of the
259 SNPs in Caucasian versus African Americans asthmatics (red)
and Caucasian versus African American non-allergic control
groups (blue) were statistically significant (Figure S1). The average
absolute allele frequency difference in asthmatic allele frequency
between Caucasian and African Americans was 0.12960.107 with
range from 0.0017 to 0.484. Non-allergic control children were
more similar between Caucasian and African American groups
than the asthmatic groups. Allele frequencies within the admixed
African American populations are intermediate between the
respective ancestral HapMap Phase 3 (European and African)
populations (data not shown).
Single SNP association, majority of SNP associations do
not overlap between European ancestry and African
American
Among children with European ancestry, significant single SNP
associations between asthmatics and non-allergic controls were
detected in 13 of the 230 SNPs in 5 of the 28 genes (p-
value=0.05). These include SNPs in IL4, SPINK5, SERPINA1,
IL9 and IL13 (Table S1). To take into account the LD correlation
among SNPs, we used a modified Bonferroni adjustment cut-off
[10] to determine the significance with a p-value of 0.00085. With
this criterion, 4 SNPs in IL4 significantly increased the risk for
asthma by approximately twofold (Table 3). In fact, IL4 rs2243250
remained significant even after the traditional and highly
conservative Bonferroni adjustment (Figure 1). Considering the
number of assays performed, IL4 showed an excess number of
significant SNPs associated with asthma (4 out of 5), while a larger
gene such as CLCA1, with 23 SNPs, showed no significant SNP
associations.
In the African American children, 14 SNPs in 6 genes were
significantly associated with asthma (p-value=0.05, Figure 1).
These included SNPs in the IL4, INSIG2, CHIA, ALOX5,
CLCA1 and CDH26 (Table S2). IL4 rs2243250 and rs2243274
were associated with asthma in both races (p-value ,0.05). In the
African American cohort, there were no significantly associated
SNPs after Bonferroni adjustment (cutoff p-value of 0.0005).
Interestingly, the minor allele frequency of these SNPs differs by
race.
To investigate if the strong single SNP association of IL4 gene is
independent of IL13, linkage disequilibrium (LD) analyses were
performed. IL13 is an adjacent cytokine gene, which lies 200 kb
away from IL4 on chromosome 5q31 and has many structural and
functional similarities with IL4 including a shared receptor
(IL4Ra). All the genotyped IL4 SNPs in Caucasians and African
Americans were studied for LD patterns. In both populations, LD
within the IL4 gene was strong. However, LD was not observed
between IL13 and IL4 in the African American population, while
weak LD was observed between IL13 and IL4 genes in Caucasians
(Figure 2). As LD is known to be highly influenced by ancestry, the
observed patterns of LD and SNP relationships indicate that these
populations are genetically different. There was no significant
difference in LD pattern between cases and control subjects in
either population (data not shown).
Replication for IL4 in both races, and discovery of
additional IL4 variants through imputation
Analysis of SNPs imputed from Affymetrix data revealed similar
significant associations with asthma. In fact, for Caucasians, the
effect sizes for the replication studies were greater than those
observed in the discovery analyses. For example, the odds ratio of
asthma for IL4 promoter SNP rs2243250 was 2.00 (95% CI 1.18–
2.75) in our discovery analysis compared with the imputed GCC/
CCC OR of 3.86 (95% CI 1.58–9.41). Further, additional SNPs
were identified through imputation studies. Notably IL4 SNPs
rs2227284 and rs2227282 increased the odds of asthma in
Caucasian children by 5.2 (95% CI 2.68–10.0 p=1.04E-06)
(Table 3, Table 4). Although the replication control cohort was
composed of adult asthmatic and non-asthmatic subjects, IL4
SNPs were significantly associated with asthma (Table 4). The
Table 2. Sample size and covariates in both Caucasian and African American population.
Variable Asthmatic Group Allergic Group Non-Allergic Controls
Caucasian African Am. Caucasian African. Am. Caucasian African Am.
Total children (n) 420 330 269 150 298 51
Children after exclusions (n)
a 413 315 261 147 298 51
Mean age (years) 10.1
b 10.3 10.3
b 10.8 12.0 11.4
Percent male 55.2% 63.2%
b,c 56.3% 48.3% 48.0% 45.1%
aIndicates the number children after children with missing call rates above 20% were removed.
bIndicates significant differences (p,0.05) with similar race non-allergic normal control children.
cIndicates significant differences (p,0.05) with similar race allergic children. African Am. indicates African American race.
doi:10.1371/journal.pone.0016522.t002
Racial Differences in Childhood Asthma
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broader implication in asthma independent of development stages.
Similarly, in the African American population, the odds of
asthma for IL4 SNP rs2243250 increased from 1.75 (95% CI
1.16–2.70) in the discovery analysis to 2.15 in the replication
analysis (Table 3, Table 4). In addition, two IL4 promoter SNPs
rs2243240 and rs2243246 discovered through imputation were
also significantly associated with asthma (p-value ,0.05) (Table 4).
Gene- gene interactions and gene networks differ by
race
To identify the SNP combination that best discriminates
between asthma cases and non-allergic controls, we explored the
gene-gene interactions (epistasis) among all 259 SNPs across the 28
candidate genes using RP.
For the Caucasian population, a total of 6 SNPs from the total
of 259 SNPs (in genes IL4, STUB1, ADRb2, IL4Ra, IL13Ra2
and CHIA) remained in the final tree from the RP process (see
Figure 3a). At the top of the tree, the most asthma predictive SNP
was rs2243250, an extensively studied IL4 promoter variant
[16,17,18,19,20,21,22,23,24,25]. Interestingly, other SNPs were
not significantly associated with asthma in univariate SNP
association analysis, but appeared to be discriminative between
asthmatic and non-allergic children in the multivariate model.
In the African American children, 5 SNPs in 5 genes together
significantly discriminate between asthmatic and non-allergic
children. INSIG2 rs4848492 was the most predictive gene
following by IL4, CHIA, ADIPOQ and ALOX5 (see Figure 3b).
Only two genes (IL4 and CHIA) were common in both races.
Ingenuity Pathways Analysis (IPA) demonstrated that RP based
interacting genes are part of an interconnected gene network that
involved in related biological activities and functional common-
alities. In Caucasian, the most enriched IPA canonical pathways in
the 6 genes (p,3.21*10
24) were IL4 signaling and T helper cell
differentiation. In African Americans, airway inflammation in
asthma and role of cytokines in mediating communication
between immune cells were the most enriched pathways among
the 5 genes (p,1.89*10
22). Gene ontology analysis of the African
American network showed enrichment for specific biological
functions, including arachidonate 5-lipoxygenase activity
(p=2.2610
26), mevalonate kinase activity (p=1.5610
23) and
interleukin-4 receptor binding (p=1.5610
23). Gene ontology
analysis of the Caucasian based Network showed cytokine binding
(p=1.9610
212), cytokine receptor activity (p=1.4610
210). And
transmembrane receptor activity (p=3.7610
26). Enriched bio-
logical process includes production of molecular mediator involved
in inflammatory response (p=9.7610
29) for AA and immune
response (p=1.0610
220) for CEU.
Discussion
To our knowledge, this is the largest candidate genes association
study that has examined racial differences in childhood asthma.
Through this systematic study, we have simultaneously studied
both Caucasian and African American asthmatic children and
demonstrated that these populations predominantly exhibit
different patterns of association between genetic variants and
asthma. To accomplish this goal we used well characterized
European ancestry and African American children who live in the
same geographic region of the greater Cincinnati area. Using both
cohorts we have shown that only 1 of 28 genes had associations in
both populations, as well as only 2 genes were common across the
two races in the recursive partitioning analysis. Indeed, different
gene networks were associated with asthma in children with
European ancestry versus African Americans suggesting that there
may be distinct mechanisms underlying the pathogenesis and
expression of asthma in these 2 subgroups. Simultaneous
investigation of risk variants across European and African
American populations enabled the identification of population
specific risk alleles and disease pathways, which may contribute to
health disparity. The results from this study may also assist in fine-
mapping of genetic associations by exploiting the differences in
linkage disequilibrium between populations to narrow the range of
marker alleles demarking regions that contain a true biologically
relevant variant.
These analyses revealed two major findings. First, we confirmed
the importance of IL4 genetic variation in the risk of pediatric
asthma, and present evidence of replication among the African-
American population. While IL4 has been consistently reported to
be associated with asthma in Caucasian, Asian, and Hispanic
Table 3. IL4 gene single locus association in Caucasian and African American population.
IL4 Asthmatics vs. Non-Allergic Controls
Caucasian African American
Frequency cases/controls= 413/298 315/51
SNP (major/minor) Function MAF MAF
Asthmatics controls OR P-value Asthmatics controls OR P-value
rs2243250 (C/T)
a Promoter 0.195 0.116 2.00 (1.45,2.75) 0.00002 0.332 0.471 0.56 (0.37,0.86) 0.008
rs2243282 (C/A) Intronic 0.180 0.117 1.81 (1.31,2.50) 0.0003 0.336 0.294 1.26 (0.79,2.02) 0.34
rs2243274 (G/A)
a Intronic 0.188 0.126 1.74 (1.27,2.38) 0.0006 0.389 0.500 0.64 (0.42, 0.96) 0.03
rs2243268 (A/C) Intronic 0.178 0.116 1.81 (1.32,2.50) 0.0003 0.250 0.220 1.22 (0.73,2.06) 0.45
rs2243263 (G/C) Intronic 0.113 0.135 0.77 (0.55,1.08) 0.13 0.167 0.265 0.54 (0.32,0.89) 0.016
rs2243248 (T/G) Promoter 0.146 0.245 0.47 (0.27,0.82) 0.008
rs2243283 (C/G) Intronic 0.152 0.039 4.4 (1.34,14.44) 0.015
Associations between asthmatic and non-allergic controls, and between allergic and non-allergic controls were tested independently and odds ratios (OR) were
determined using logistic regression based on the minor allele after adjusting for age, gender and population stratification.
aIndicates major and minor alleles are reversed in African American children. Confidence intervals are indicated in parenthesis, MAF stands for minor allele frequency.
doi:10.1371/journal.pone.0016522.t003
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corrected significance in the Caucasian children (rs2243250 and
rs2243274) replicated (p,0.05) in the African American children
(Table 3). While non-coding IL4 rare variants have been
associated with asthma susceptibility in African Americans [26],
the association of these two SNPs is novel to this population. This
result suggests that some common immunological mechanisms (at
these variants) may underlie childhood asthma across different
ethnic backgrounds. However, most studied SNPs showed no
evidence of replication between Caucasian and African American
children. For example, IL4 SNPs, which are highly significant in
the Caucasian group such as rs2243282 and rs2243268 didn’t
reach 5% significance level in African American population. In
contrast, SNP rs4448492 in the INSIG2 gene was associated
(P=0.002) with asthma in African American population. Howev-
er, this SNP was not significant even without adjustment (at 5%) in
Caucasian population. Several SNPs have shown different allele
frequencies between the two races (Figure S1). This result suggests
that these genes do not harbor susceptibility variants common to
both races due to a) variation in signatures of natural selection
resulting in differences in allele frequencies; b) varying linkage
disequilibrium patterns at causal loci across different populations
(as shown for IL4 – Figure 2); and/or (c) there may be common
and distinct pathways that contribute to the development and
expression of asthma phenotypes between these two groups. It also
remains possible that we do not have sufficient statistical power
with the current sample size to detect statistical significance,
although this is unlikely for the observed lack of association of
INSIG2 in the Caucasian subset. To determine the power of this
to detect expected ORs for IL4 coding SNPs in both Caucasian
and African American population, we conducted an ad-hoc
analysis with the software Quanto [27]. With our sample size, we
have 96% and 71% power to detect the association of rs2243250
with asthma in Caucasian and African ancestry population,
respectively. This ad-hoc power analysis provides sufficient
evidence that we have high power in Caucasian and moderate
Figure 1. Associations between European and African Ancestry asthmatics vs. non-allergic controls. Associations between the 230 total
SNPs within the 28 candidate genes were tested using the additive model after adjusting for age, gender and population stratification. The upper line
corresponds to the conservative Bonferroni adjusted p value 0.00022. The middle line corresponds to the Bonferroni adjusted p value 0.00085
considering a LD correlation of 0.25. SNPs significant at this level (all in IL4) include rs2243250, rs243268, rs2243274 and rs43282. The lower line isa
nominal significance p value=0.05. SNPs are plotted on the x-axis according to their position on each candidate gene across the chromosome
against association with asthma on the y axis (shown as log10 p value).
doi:10.1371/journal.pone.0016522.g001
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population. The positions of SNPs within the IL4 and IL13 genes are shown above the plot. Values in boxes are r
2 measures on a decimal scale (i.e. 97
represent r
2=0.97), indicating extent of LD between two SNPs. Box without numbers have r
2=1. The shade of each square indicates the strength of
the LD relationship between pairs of SNPs.
doi:10.1371/journal.pone.0016522.g002
Table 4. IL4 gene imputation based association/replication in Caucasian and African American population.
IL4
Asthmatic (GCC) Vs. non-asthmatic
controls (CCC)
Caucasian
Childhood Asthma Management
Program, CAMP (dbGaP)
African American
Frequency cases/controls= 74/211 42 trios
SNP ID Function OR* P-value OR** P-value
Replication association rs2243250 Promoter 3.86 0.003 2.15 0.019
rs2243282 Intronic 3.86 0.003 1.3 0.53
rs2243274 Intronic 2.97 0.0076 1.73 0.086
rs2243268 Intronic 3.86 0.003 1.08 0.84
rs2243263 Intronic 2.22 0.04
rs2243248 Promoter 1.38 0.49
rs2243283 Intronic 1 1
Discovery of untyped
SNP association
rs2070874 Promoter 3.86 0.003
rs734244 Intron 3.86 0.003
rs2227284 Intron 5.17 1.04E-06
rs2227282 Intron 5.17 1.04E-06
rs2243266 Intron 3.86 0.003
rs2243267 Intron 3.86 0.003
rs2243288 Intron 2.97 0.0076
rs2243289 Intron 3.86 0.003
rs2243290 Intron 3.86 0.003
rs2243240 Promoter 0 0.0455
rs2243246 Promoter 0.3571 0.03895
rs2243252 Intron 0 0.0455
doi:10.1371/journal.pone.0016522.t004
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replication in these two populations emphasizes the need to
consider ancestry background and detailed examination of
population SNPs allele frequency across populations of different
and mixed ancestry as well as non-genetic factors.
Secondly, Using RP, we report for the first time an interaction
of six genes affecting European ancestry pediatric asthma:
rs2243250 (IL4), rs6597 (STUB1) rs11168070 (ADRb2),
rs3024676 (IL4Ra), rs638376 (IL13Ra2) and rs3806446 (CHIA).
These SNPs resulted in 62% accuracy of asthmatic and non-
allergic classification. Similarly seven SNPs in five genes rs4848492
(INSIG2), rs2243283 (IL4), rs4423003 (CHIA), rs2243283 (IL4),
rs12495941 (ADIPOQ), rs2243268 (IL4), and rs2291427
(ALOX5) in African American children had 77% discriminate
power between asthmatic and non-allergic individuals. The
combination of genotypes in these interactive SNPs can help to
pin-point individuals with greater asthma risk (Figure 3). Impor-
tantly, the RP method may elucidate associations, which may be
missed using single SNP association. For example, variants in
STUB1 and ADRb2 genes in Caucasian and variants in CHIA
and ADIPOQ genes in African American were not associated with
asthma in the single SNP analysis; however, in conditional
inference framework taking rs2243250 and rs4848492 as a major
discriminatory SNPs in Caucasian and African American
respectively, variation in these genes is highly associated with
asthma (p,0.01). Kabesch et al. [17] reported strong gene-gene
interactions among genes involving Th3-cell differentiation and
signaling pathways. Our study showed that using the RP
approach, SNPs that are weakly or not associated in the univariate
analysis could discriminate between asthma and non-allergic
control individuals in both races. This finding clearly indicates that
the effect of one gene may not be disclosed if the effect of another
gene is not considered [28], suggesting that the true effect may be
driven by gene-gene interaction, rather than by the main effect of
each gene by itself.
Further analysis using Ingenuity Pathways Analysis (IPA)
revealed that these RP based interactive genes belong to an
interconnected and interactive gene network, indicating that they
are involved in related biological activities and have functional
commonalities (Figure 4a, b). We also used IPA to characterize the
enrichment of specific pathway components into functionally
differentiated gene groups [29]. The most enriched (p#3*10
24)
canonical pathway in Caucasian population was IL4 signaling
whereas airway inflammation in asthma was the most enriched
(p,1.36*10
23) pathway in African American (data not shown).
Differences in the genetic architecture of individuals may have
affected determinant pathways in different ways. However, both
enriched IPA pathways in both races have essential roles in asthma
pathogenesis [30]. In network analysis, IL4 was the major hub
gene in both Caucasian and African American (Figure 4a, b).
These results were not unexpected given that IL4 is a critical
effector in the generation of allergic inflammation and IgE
Figure 3. RP based gene-gene interactions of asthmatics vs. non-allergic controls. Using the program PARTY (implemented in R), non-
parametric recursive partitioning was performed to identify combination of SNPs that together had the greatest ability to discriminate between
asthmatic and non-allergic controls. All the 257 SNPs within the 28 candidate genes were evaluated in the process. For the stopping criterion we use
the nominal level of the conditional independence test of a=0.05. The final trees were enough to achieve 62% discrimination accuracy between the
asthmatic and non-allergic control individuals for Caucasian population and 77% for African American population. The number of subgroup is
indicated below each terminal node.
doi:10.1371/journal.pone.0016522.g003
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Th2 profile of allergic subjects [31]. IL4 is central to B cell heavy
class switching from immunoglobulin M (IgM) to IgE, and to the
maturation of T helper (Th) cells towards the Th2 phenotype [32].
One of the variants (rs2243250), which was most strongly
associated with asthma, lies in the IL4 promoter region which
has been implicated and replicated in more than 11 studies
[17,19,20,21,22,23,25,33,34]. IL4 rs2243250 is a C-to-T mutation
that lies upstream from the open reading frame of the gene. It has
previously been shown to increase promoter activity of IL4
transcription and was associated with elevated levels of serum IgE
in asthmatic families [25].
In critically evaluating our results, it is important to note that
our analyses, and hence interpretations, are subject to several
limitations. First, SNP allele frequencies and association were
determined by using relatively small sample sizes (see Methods).
However, it should be noted that large sample sizes may not help
powering genetic studies and improve our understanding of the
genetic underpinnings of allergy phenotypes as much as precise
phenotyping [35]. In the present study we show that use of well-
characterized control populations (see Methods) in genetic
association studies can overcome relatively small sample sizes to
identify risk variants. Further, in order to overcome the relatively
small sample size in the AA cohort, we sought to replicate our
findings using publically available datasets but found similarly
small AA cohorts. Thus, there is a clear need for larger AA cohorts
in future studies. Second, to reduce the chance of potential false
positive results from multiple testing, we corrected the p-values
using Bonferroni adjustment which accounted for the LD among
SNPs. As the Bonferroni adjustment is notably conservative, the
LD adjustment provides minimization of false positives. We
believe that this approach provides a reasonable balance between
type I and type II error. Nonetheless, it is likely that we are missing
true associations, which may provide insight into racial differences
and similarities. Third, the environmental influences between our
case and control groups may be different, especially between
adults and children. Fourth, our study showed a positive
association, but it does not always imply causality. Hence, further
studies are needed to confirm the findings and to identify
functional variants causally linked to asthma risk. The present
study has notable strengths. First, we were able to conduct the
analyses separately in each race, and were therefore able to
account for the differences in allele frequencies, disease preva-
lence, and linkage disequilibrium patterns between these subpop-
ulations. Second, our study used a custom designed array that
includes more coverage of candidate genes/SNPs of interest and
the inclusion of ancestry informative markers (AIMs) to account
hidden ethnic variations.
In summary, through our systematic and comprehensive screen
of variants in asthmatic children who live in the same geographic
Figure 4. Ingenuity Pathway Analysis (IPA) Interactive network. IPA network for recursive partitioning prioritized genes. Genes with red node
are focused genes in our analysis, others are generated through the network analysis from the Ingenuity Pathways Knowledge Base (http://www.
ingenuity.com). Edges are displayed with labels that describe the nature of the relationship between the nodes. All edges are supported by at least
one reference from the literature, or from canonical information stored in the Ingenuity Pathways Knowledge Base. Edges are displayed with labels
that describe the nature of the relationship between the nodes. The lines between genes represent known interactions, with solid lines representing
direct interactions and dashed lines representing indirect interactions. Nodes are displayed using various shapes that represent the functional class of
the gene product. Nodes are displayed using various shapes that represent the functional class of the gene product (see legend).
doi:10.1371/journal.pone.0016522.g004
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variation in both Caucasians and African American. Variants
found in populations of both African and European ancestry may
represent more universally important genes to the disorder [36].
The replication of IL4 SNPs in African ancestry can also
potentially aid in refining and fine mapping associations due to
the unique short range LD in this ethnicity. The use of a
population with short LD will result in the greatest localization
success rate in distinguishing the causal SNP from its neighbors.
Based on the overall lack of SNPs concordance in association
between European and African American asthmatic children, we
suspect that rare and/or population-specific risk alleles may
explain some of the associations in asthma, pointing to genetic
heterogeneity in susceptibility alleles. These results also underline
the importance of understanding differences in biologic and
genetic factors driving asthma in different ancestral populations.
Future fine-mapping and deep sequencing studies are needed to
determine whether or not other SNPs can be found associated in
African Americans as well as to identify both common and/or rare
risk-causing alleles in the associated regions.
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